Skip to main content
Skip to main content
CLOV logo

Clover Health Investments, Corp. (CLOV)

$5.12 +$0.06 (+1.09%) |Weak · 36
Bottom line: HOLD — our Council read (36/100) and AI Score (36/100) broadly agree.
MCap: $2.65B| P/E Ratio: -10.9| Vol: 3.35M| Target: $3.00 (-41.3%)| 52-wk range: $1.58 – $3.92
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Clover Health Investments, Corp. (CLOV) trades at $5.12 with AI Score 36/100 (Grade D). Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States, leveraging its Clover Assistant software platform. Market cap: $2.65B, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States, leveraging its Clover Assistant software platform. The company provides health plans for Medicare-eligible consumers, focusing on improving healthcare outcomes through technology and data analytics.

CLOV stock analysis for 2026: Analysts have set a consensus price target of $3.00 for Clover Health Investments, Corp., suggesting 41.3% downside from the current price of $5.12. The AI MoonshotScore is 36/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
HOLD 36/100 · D

CLOV: 1/1 perspectives are bearish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Clover Health Investments, Corp. (CLOV) Healthcare & Pipeline Overview

CEOAndrew Toy
Employees570
HeadquartersFranklin, TN, US
IPO Year2020

Clover Health Investments, Corp. is a technology-driven Medicare Advantage insurer, providing health plans through its Clover Assistant platform. The company focuses on leveraging data and technology to improve healthcare outcomes for Medicare-eligible consumers in the United States, differentiating itself through its software-centric approach within the healthcare sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for CLOV?

Clover Health Investments, Corp. presents a compelling investment thesis centered on its technology-driven approach to the Medicare Advantage market. The company's Clover Assistant platform aims to improve healthcare outcomes and reduce costs by providing physicians with real-time data and insights. With a gross margin of 42.5%, Clover Health demonstrates its ability to generate value from its insurance offerings. Key growth catalysts include expanding its geographic footprint and increasing penetration within existing markets. However, potential risks include regulatory changes in the healthcare industry and competition from larger, more established players. The company's current market capitalization is $1.11 billion, reflecting investor sentiment regarding its growth potential and profitability challenges. Achieving profitability, indicated by its current profit margin of -2.6%, remains a critical factor for long-term success.

Based on FMP financials and quantitative analysis

CLOV Key Highlights

  • Market Cap of $2.65B reflects investor valuation of Clover Health's growth potential in the Medicare Advantage market.
  • Gross Margin of 42.5% indicates the company's ability to generate value from its insurance offerings and manage healthcare costs effectively.
  • Profit Margin of -2.6% highlights the company's ongoing efforts to achieve profitability and scale its operations efficiently.
  • Beta of 2.25 suggests higher volatility compared to the market, reflecting the growth stage and potential risks associated with the company.
  • Clover Assistant platform is a key differentiator, providing physicians with real-time data and insights to improve patient care and reduce costs.

Who Are CLOV's Competitors?

CLOV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
UNH UnitedHealth Group Incorporated $425.76 +1.86% $386.65B 76
HUM Humana Inc. $394.62 +0.45% $47.38B 80
CNC Centene Corporation $65.86 -0.29% $32.52B 72
NEGXF NexgenRx Inc. $0.33 +0.00% $23.11M 53
ALHC Alignment Healthcare, Inc. $24.05 -2.08% $4.97B 52
GTS Triple-S Management Corporation $35.99 +1.04% 52
BMGL Basel Medical Group Ltd $6.58 -6.61% $10.29M 51
MRAI Marpai, Inc. $0.70 -0.00% $13.89M 40

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CLOV's Key Strengths?

  • Technology-driven platform (Clover Assistant) for data analytics and care management.
  • Focus on value-based care and improved healthcare outcomes.
  • Partnerships with physicians and healthcare providers.
  • Experienced management team with expertise in healthcare and technology.

What Are CLOV's Weaknesses?

  • Relatively small market share compared to larger competitors.
  • Profitability challenges and ongoing losses.
  • Dependence on government regulations and reimbursement rates.
  • Limited geographic presence compared to national players.

What Could Drive CLOV Stock Higher?

  • Expansion into new geographic markets, increasing the company's reach and potential customer base.
  • Continued development and enhancement of the Clover Assistant platform, improving its capabilities and value proposition.
  • Strategic partnerships with healthcare providers and organizations, expanding the company's network and access to patients.
  • Focus on value-based care initiatives, aligning incentives and improving healthcare outcomes.

What Are the Key Risks for CLOV?

  • Negative return on equity (-17.1%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Insider selling — insiders were net sellers of roughly $3.4M recently.
  • Regulatory changes and reimbursement rate cuts in the healthcare industry, impacting the company's revenue and profitability.
  • Competition from larger, more established players in the Medicare Advantage market, limiting the company's growth potential.
  • Economic downturn and decreased consumer spending, affecting the company's ability to attract and retain members.
  • Cybersecurity risks and data breaches, compromising patient information and damaging the company's reputation.
  • Achieving and maintaining profitability, given the company's history of losses.

What Are the Growth Opportunities for CLOV?

  • Geographic Expansion: Clover Health has the opportunity to expand its geographic footprint by entering new markets and offering its Medicare Advantage plans to a broader population. This expansion can be achieved through strategic partnerships, acquisitions, or organic growth initiatives. The Medicare Advantage market is projected to continue growing, providing ample opportunities for Clover Health to increase its market share and revenue. Timeline: Ongoing.
  • Increased Penetration in Existing Markets: Clover Health can focus on increasing its market share within its existing markets by enhancing its marketing efforts, improving its product offerings, and strengthening its relationships with physicians and healthcare providers. By providing superior service and value to its members, Clover Health can attract new customers and retain existing ones. Timeline: Ongoing.
  • Expansion of Clover Assistant Platform: Clover Health can further develop and expand the capabilities of its Clover Assistant platform to provide additional value to physicians and patients. This can include incorporating new features, integrating with other healthcare systems, and leveraging data analytics to improve healthcare outcomes. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Clover Health can pursue strategic partnerships and acquisitions to expand its capabilities, enter new markets, and gain access to new technologies. This can include partnering with healthcare providers, technology companies, or other healthcare organizations. Timeline: Ongoing.
  • Focus on Non-Insurance Businesses: Clover Health can continue to develop and expand its non-insurance businesses to diversify its revenue streams and reduce its reliance on its insurance offerings. This can include providing healthcare services, developing healthcare technology solutions, or offering other related products and services. Timeline: Ongoing.

What Opportunities Does CLOV Have?

  • Expansion into new geographic markets.
  • Increased penetration within existing markets.
  • Development of new products and services.
  • Strategic partnerships and acquisitions.

What Threats Does CLOV Face?

  • Competition from larger, more established players.
  • Regulatory changes and reimbursement rate cuts.
  • Economic downturn and decreased consumer spending.
  • Cybersecurity risks and data breaches.

What Are CLOV's Competitive Advantages?

  • Technology-driven platform (Clover Assistant) provides a competitive edge in data analytics and care management.
  • Focus on value-based care aligns incentives and improves healthcare outcomes.
  • Partnerships with physicians and healthcare providers create a network effect.
  • Proprietary data and insights provide a competitive advantage in risk management and cost control.

What Does CLOV Do?

Clover Health Investments, Corp., founded in 2014 and headquartered in Franklin, Tennessee, operates as a Medicare Advantage insurer in the United States. The company distinguishes itself through its technology-driven approach to healthcare, primarily through its Clover Assistant platform. This software is designed to provide preferred provider organization (PPO) and health maintenance organization (HMO) health plans for Medicare-eligible consumers. Clover Health's core mission revolves around improving healthcare outcomes and reducing costs by leveraging data analytics and technology to empower physicians and patients. The Clover Assistant platform provides physicians with real-time data and insights, enabling them to make more informed decisions regarding patient care. This technology aims to enhance the quality of care, improve patient engagement, and streamline administrative processes. Clover Health's business model focuses on providing comprehensive healthcare coverage while simultaneously driving efficiency and innovation within the healthcare system. In addition to its insurance offerings, Clover Health also focuses on non-insurance businesses, further diversifying its revenue streams and expanding its reach within the healthcare industry. The company's strategic focus on technology and data analytics positions it as a disruptor in the traditional Medicare Advantage market, with the goal of delivering better healthcare outcomes at lower costs.

What Products and Services Does CLOV Offer?

  • Provides Medicare Advantage health plans to eligible consumers in the United States.
  • Operates the Clover Assistant, a software platform for healthcare providers.
  • Offers preferred provider organization (PPO) and health maintenance organization (HMO) plans.
  • Focuses on improving healthcare outcomes through data analytics and technology.
  • Partners with physicians to provide better care and reduce costs.
  • Engages in non-insurance businesses to diversify revenue streams.

How Does CLOV Make Money?

  • Generates revenue from premiums paid by Medicare Advantage members.
  • Utilizes the Clover Assistant platform to manage healthcare costs and improve outcomes.
  • Partners with healthcare providers to deliver care to its members.
  • Focuses on value-based care to align incentives and improve quality.

What Industry Does CLOV Operate In?

Clover Health operates within the dynamic and competitive Medicare Advantage market, which is experiencing significant growth due to the aging population and increasing demand for comprehensive healthcare coverage. The industry is characterized by a mix of established players, such as UnitedHealth Group and Humana, and emerging technology-driven companies like Clover Health. Market trends include a growing emphasis on value-based care, data analytics, and personalized healthcare solutions. Clover Health's technology-centric approach and focus on improving healthcare outcomes position it as a potential disruptor in this evolving landscape.

Who Are CLOV's Key Customers?

  • Medicare-eligible individuals seeking comprehensive healthcare coverage.
  • Physicians and healthcare providers who use the Clover Assistant platform.
  • Healthcare organizations that partner with Clover Health to improve care delivery.
AI Confidence: 71% Updated: May 10, 2026

Company Profile

Clover Health Investments, Corp. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Franklin, US. The company is led by CEO Andrew Toy. CLOV has traded publicly since 2020.

ROE -17%Key Financial Metrics

Return on equity for Clover Health Investments, Corp. stands at -17.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -8.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 2.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -2.1%, the inverse of the P/E and a quick read on earnings relative to price.

CLOV Valuation & Market Position

With a $2.65B market cap, Clover Health Investments, Corp. sits in the mid-cap segment of the market. Relative to its peer group, CLOV's quantitative score of 36/100 is below the peer average of 67/100.

Quarterly Financial Performance: Clover Health Investments, Corp.

Revenue for Clover Health Investments, Corp. came in at $749.2M during Q1 2026, a 53.6% improvement versus the preceding quarter. The company recorded net income of $27.3M, with diluted EPS of $0.05. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, CLOV averaged $-0.03 in diluted EPS.

F-Score 3/9Financial Health

Clover Health Investments, Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 2.95 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project Clover Health Investments, Corp. revenue of about $2.91B for fiscal 2026, with EPS near $0.04.

Net buyingInsider Activity

Over the past six months, Clover Health Investments, Corp. insiders filed 28 SEC Form 4 transactions — 23 sales and 5 purchases. On net that is roughly 671K shares acquired (about $3.4M) — insiders putting money in tends to read as conviction.

CLOV Financials

Fundamental Snapshot

Revenue Growth (FY)
+40.3%
Net Income Growth (FY)
-98.9%
EPS Growth (FY)
-93.6%
Free Cash Flow Growth (FY)
-307.2%
Return on Equity (TTM)
-17.1%
Current Ratio
1.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Technology-driven platform (Clover Assistant) for data analytics and care management.
  • Focus on value-based care and improved healthcare outcomes.
  • Partnerships with physicians and healthcare providers.
  • Experienced management team with expertise in healthcare and technology.

Bear Case

  • Relatively small market share compared to larger competitors.
  • Profitability challenges and ongoing losses.
  • Dependence on government regulations and reimbursement rates.
  • Limited geographic presence compared to national players.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $749M $27M $0.05
Q4 2025 $488M -$49M -$0.10
Q3 2025 $497M -$24M -$0.05
Q2 2025 $478M -$11M -$0.02

Based on FMP financials and quantitative analysis

CLOV Latest News

CLOV Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLOV.

Price Targets

Consensus target: $3.00

CLOV MoonshotScore

36/100

What does this score mean?

The MoonshotScore rates CLOV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Andrew Toy

CEO

Andrew Toy serves as the CEO of Clover Health Investments, Corp. His background spans technology and management, bringing a unique perspective to the healthcare industry. Prior to Clover Health, Toy held leadership positions at Google, where he focused on product management and engineering. His experience includes developing and launching innovative products, managing large teams, and driving strategic initiatives. Toy's expertise in technology and data analytics is instrumental in guiding Clover Health's mission to improve healthcare outcomes through its Clover Assistant platform.

Track Record: Since becoming CEO, Andrew Toy has focused on scaling Clover Health's operations and expanding its market presence. Key achievements include enhancing the Clover Assistant platform, improving member engagement, and driving revenue growth. Toy's leadership has been instrumental in navigating the complex regulatory landscape and positioning Clover Health as a technology-driven disruptor in the Medicare Advantage market.

Common Questions About CLOV (Healthcare)

What does Clover Health Investments, Corp. do?

Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States, leveraging its Clover Assistant platform to provide health plans for Medicare-eligible consumers. The company's core focus is on improving healthcare outcomes and reducing costs through data analytics and technology. The Clover Assistant platform provides physicians with real-time data and insights, enabling them to make more informed decisions regarding patient care. Clover Health's business model centers around providing comprehensive healthcare coverage while driving efficiency and innovation within the healthcare system.

What do analysts say about CLOV stock?

Analyst coverage of Clover Health Investments, Corp. is mixed, with opinions varying on the company's growth potential and profitability prospects. Key valuation metrics, such as price-to-sales ratio and enterprise value-to-EBITDA, are closely monitored to assess the company's financial performance. Growth considerations include the company's ability to expand its market share, improve its Clover Assistant platform, and achieve profitability. Analyst consensus typically reflects a neutral to slightly positive outlook, with a focus on the company's long-term potential in the Medicare Advantage market.

What are the main risks for CLOV?

Clover Health Investments, Corp. faces several key risks, including regulatory changes in the healthcare industry, competition from larger players, and economic downturns. Regulatory changes, such as reimbursement rate cuts, could significantly impact the company's revenue and profitability. Competition from established players in the Medicare Advantage market poses a challenge to Clover Health's growth potential. Economic downturns could affect the company's ability to attract and retain members. Additionally, cybersecurity risks and data breaches are a concern, as they could compromise patient information and damage the company's reputation. Achieving and maintaining profitability remains a critical risk for the company.

What are the key factors to evaluate for CLOV?

Clover Health Investments, Corp. (CLOV) holds an AI score of 36/100 (low). Analysts target $3.00 (-41%). Not financial advice.

How frequently does CLOV data refresh on this page?

CLOV prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven CLOV's recent stock price performance?

Clover Health Investments, Corp. (CLOV) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Technology-driven platform (Clover Assistant) for data analytics and care management. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CLOV overvalued or undervalued right now?

Valuing Clover Health Investments, Corp. (CLOV) requires multiple metrics. Analysts target $3.00 (-41%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying CLOV?

Before investing in Clover Health Investments, Corp. (CLOV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available sources and may be subject to change.
  • Financial data is as of the latest available reporting period.
Data Sources

Popular Stocks